Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average) (2009 - 2025)

Charles River Laboratories International's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $49.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) fell 3.53% year-over-year to $49.6 million; the TTM figure through Dec 2025 stood at $49.6 million (down 3.53% YoY), while the FY2025 annual figure was $49.6 million, down 3.53% from the prior year.
• Shares Outstanding (Weighted Average) was $49.6 million for Q4 2025 at Charles River Laboratories International, roughly flat from $49.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $51.5 million in Q2 2024 to a low of $49.6 million in Q4 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $50.7 million across 5 years, with a median of $50.8 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Weighted Average) gained 1.61% in 2021, then retreated 3.53% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $50.3 million in 2021, then rose by 1.03% to $50.8 million in 2022, then rose by 0.82% to $51.2 million in 2023, then climbed by 0.3% to $51.4 million in 2024, then decreased by 3.53% to $49.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $49.6 million (Q4 2025), $49.7 million (Q3 2025), and $49.9 million (Q2 2025), per Business Quant data.